Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TYRA | Common Stock | Award | $41.4M | +3.18M | +60.04% | $13.01 | 8.48M | Feb 6, 2024 | See footnotes | F1, F2 |
holding | TYRA | Common Stock | 1.5M | Feb 6, 2024 | See footnotes | F2, F3 | |||||
holding | TYRA | Common Stock | 443K | Feb 6, 2024 | See footnotes | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TYRA | Pre-Funded Warrants (Right to Buy) | Award | $20M | +1.54M | $13.01 | 1.54M | Feb 6, 2024 | Common Stock | 1.54M | $0.00 | See footnotes | F1, F2, F5 |
Id | Content |
---|---|
F1 | These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). |
F2 | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
F3 | These securities are held directly by the Nexus Fund. |
F4 | These securities are held directly by the Account. |
F5 | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. |
Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.